phase 1 adaptive dose-escalation study of mycophenolate mofetil (MMF) in combination with temozolomide (TMZ) for patients with newly diagnosed glioblastoma

NIH RePORTER · NIH · P50 · $439,418 · view on reporter.nih.gov ↗

Key facts

NIH application ID: 10468354
Project number: 5P50CA221747-04
Recipient: NORTHWESTERN UNIVERSITY
Principal Investigator: Atique U. Ahmed
Activity code: P50
Funding institute: NIH
Fiscal year: 2021
Award amount: $439,418
Award type: 5
Project period: 2018-08-17 → 2023-07-31